Bluejay Diagnostics, Inc. (BJDX)
USD 3.25
(-12.16%)
USD 3.25
(-12.16%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -10.31 Million USD | -10.66% |
| 2022 | -9.31 Million USD | -188.46% |
| 2021 | -3.23 Million USD | -169.99% |
| 2020 | -1.19 Million USD | 26.67% |
| 2019 | -1.63 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.89 Million USD | 21.94% |
| 2024 Q1 | -2.42 Million USD | -1.73% |
| 2023 Q2 | -2.9 Million USD | -2.25% |
| 2023 FY | -10.31 Million USD | -10.66% |
| 2023 Q4 | -2.38 Million USD | -1.94% |
| 2023 Q3 | -2.34 Million USD | 19.37% |
| 2023 Q1 | -2.83 Million USD | -15.74% |
| 2022 Q2 | -1.98 Million USD | 3.99% |
| 2022 Q1 | -2.06 Million USD | -50.65% |
| 2022 FY | -9.31 Million USD | -188.46% |
| 2022 Q4 | -2.45 Million USD | 12.69% |
| 2022 Q3 | -2.81 Million USD | -41.52% |
| 2021 Q2 | -666.07 Thousand USD | -185.63% |
| 2021 Q4 | -1.37 Million USD | -43.31% |
| 2021 Q3 | -957.98 Thousand USD | -43.83% |
| 2021 Q1 | -233.19 Thousand USD | 59.92% |
| 2021 FY | -3.23 Million USD | -169.99% |
| 2020 Q1 | -233.22 Thousand USD | 0.0% |
| 2020 Q4 | -581.77 Thousand USD | -292.65% |
| 2020 Q3 | -148.16 Thousand USD | 36.47% |
| 2020 Q2 | -233.22 Thousand USD | 0.0% |
| 2020 FY | -1.19 Million USD | 26.67% |
| 2019 FY | -1.63 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 28.2% |
| Cerus Corporation | -30.05 Million USD | 65.69% |
| OrthoPediatrics Corp. | -25.76 Million USD | 59.981% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 2.92% |
| Talis Biomedical Corporation | -66.81 Million USD | 84.568% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 40.384% |
| Inogen, Inc. | -109.38 Million USD | 90.574% |
| Spectral AI, Inc. | -12.98 Million USD | 20.585% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 83.526% |
| CVRx, Inc. | -43.1 Million USD | 76.078% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -192.268% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 17.032% |
| Orthofix Medical Inc. | -139.11 Million USD | 92.588% |
| Venus Concept Inc. | -28.3 Million USD | 63.576% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 80.915% |
| Bioventus Inc. | -81.72 Million USD | 87.383% |
| BrainsWay Ltd. | -4.92 Million USD | -109.28% |
| Envoy Medical, Inc. | -18.37 Million USD | 43.872% |
| electroCore, Inc. | -18.8 Million USD | 45.168% |
| IceCure Medical Ltd | -15.57 Million USD | 33.801% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 78.732% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 40.287% |
| MaxCyte, Inc. | -48.29 Million USD | 78.651% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 13.752% |
| Nexalin Technology, Inc. | -5.69 Million USD | -81.016% |
| PAVmed Inc | -68.79 Million USD | 85.012% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 81.77% |
| RxSight, Inc. | -50.08 Million USD | 79.413% |
| Sight Sciences, Inc. | -57.27 Million USD | 81.997% |
| SI-BONE, Inc. | -46.93 Million USD | 78.029% |
| TELA Bio, Inc. | -44.07 Million USD | 76.605% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 80.958% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 79.95% |
| LivaNova PLC | -68.49 Million USD | 84.947% |
| 908 Devices Inc. | -42.75 Million USD | 75.885% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 94.053% |
| Nemaura Medical Inc. | -9.59 Million USD | -7.462% |
| NeuroPace, Inc. | -27.17 Million USD | 62.055% |
| LENSAR, Inc. | -12.22 Million USD | 15.682% |
| Apyx Medical Corporation | -17.25 Million USD | 40.256% |
| Cutera, Inc. | -156.23 Million USD | 93.4% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -19.842% |
| BioSig Technologies, Inc. | -28.51 Million USD | 63.836% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 88.234% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 54.062% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 109.246% |
| Axonics, Inc. | -26.05 Million USD | 60.428% |
| Outset Medical, Inc. | -169.77 Million USD | 93.926% |
| IRIDEX Corporation | -10 Million USD | -3.04% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 90.555% |
| IRadimed Corporation | 20.03 Million USD | 151.465% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -25.06% |
| INVO Bioscience, Inc. | -6.76 Million USD | -52.372% |
| Telesis Bio, Inc. | -35.15 Million USD | 70.665% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 171.955% |
| Varex Imaging Corporation | 32.1 Million USD | 132.122% |
| Quipt Home Medical Corp. | 3.91 Million USD | 363.108% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 15.015% |
| Pulmonx Corporation | -61.93 Million USD | 83.352% |
| Dynatronics Corporation | -2.27 Million USD | -353.629% |
| Modular Medical, Inc. | -17.52 Million USD | 41.176% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 29.563% |
| Semler Scientific, Inc. | 22.25 Million USD | 146.33% |
| InMode Ltd. | 195.66 Million USD | 105.27% |
| Bruker Corporation | 436.9 Million USD | 102.36% |
| Cytosorbents Corporation | -31.2 Million USD | 66.961% |
| DexCom, Inc. | 597.7 Million USD | 101.725% |
| Align Technology, Inc. | 643.33 Million USD | 101.603% |
| Viveve Medical, Inc. | -21.55 Million USD | 52.159% |
| ZimVie Inc. | -30.93 Million USD | 66.672% |
| Movano Inc. | -29.69 Million USD | 65.27% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 62.969% |
| Nexalin Technology, Inc. | -5.69 Million USD | -81.016% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -192.268% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 95.579% |
| Profound Medical Corp. | -28.61 Million USD | 63.967% |
| Insulet Corporation | 220 Million USD | 104.687% |
| enVVeno Medical Corporation | -25.23 Million USD | 59.144% |
| Surmodics, Inc. | -5.64 Million USD | -82.661% |
| iCAD, Inc. | -7.68 Million USD | -34.103% |
| Nuwellis, Inc. | -17.63 Million USD | 41.513% |
| Biotricity, Inc. | -8.82 Million USD | -16.798% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 91.762% |
| Aethlon Medical, Inc. | -12.63 Million USD | 18.402% |
| InspireMD, Inc. | -21.14 Million USD | 51.231% |
| PAVmed Inc. | -68.79 Million USD | 85.012% |
| BIOLASE, Inc. | -17.93 Million USD | 42.514% |
| Beyond Air, Inc. | -63 Million USD | 83.635% |
| FONAR Corporation | 16.53 Million USD | 162.359% |
| AxoGen, Inc. | -21.46 Million USD | 51.956% |
| Vivani Medical, Inc. | -26.96 Million USD | 61.761% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 157.154% |
| Inari Medical, Inc. | -14.03 Million USD | 26.516% |
| UFP Technologies, Inc. | 57.66 Million USD | 117.882% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -109.254% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -63.52% |
| Tenon Medical, Inc. | -15.72 Million USD | 34.436% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -37.961% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 75.855% |
| AdaptHealth Corp. | -598.4 Million USD | 98.277% |
| Sintx Technologies, Inc. | -13.35 Million USD | 22.809% |
| NanoVibronix, Inc. | -3.43 Million USD | -200.094% |
| Quanterix Corporation | -49.7 Million USD | 79.254% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 15.015% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -2599.271% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 96.917% |
| TransMedics Group, Inc. | -28.72 Million USD | 64.106% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 56.331% |
| NeuroMetrix, Inc. | -7.15 Million USD | -44.182% |
| Hyperfine, Inc. | -48.11 Million USD | 78.57% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 84.143% |
| Biomerica, Inc. | -6.36 Million USD | -61.948% |
| Bone Biologics Corporation | -9.42 Million USD | -9.364% |
| AVITA Medical, Inc. | -40.4 Million USD | 74.479% |
| Silk Road Medical, Inc | -59.27 Million USD | 82.603% |